Table of Contents
Chemotherapy Research and Practice
Volume 2010, Article ID 506047, 5 pages
http://dx.doi.org/10.1155/2010/506047
Review Article

From Cisplatin-Containing Sequential Radiochemotherapy towards Concurrent Treatment for Patients with Inoperable Locoregional Non-Small Cell Lung Cancer: Still Unanswered Questions

1Department of Radiation Oncology, Academic Medical Center (AMC), University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
2Department of Radiation Oncology, Netherlands Cancer Institute/Antoni Van Leeuwenhoek Hospital, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands

Received 10 August 2010; Revised 18 November 2010; Accepted 25 November 2010

Academic Editor: Vito Lorusso

Copyright © 2010 C. C. E. Koning et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Perez, K. Stanley, G. Grundy et al., “Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group,” Cancer, vol. 50, no. 6, pp. 1091–1099, 1982. View at Google Scholar · View at Scopus
  2. F. M. Kong, R. K. Ten Haken, M. J. Schipper et al., “High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 2, pp. 324–333, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. I. Saunders and S. Dische, “Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus,” International Journal of Radiation Oncology Biology Physics, vol. 19, no. 5, pp. 1211–1215, 1990. View at Google Scholar · View at Scopus
  4. R. O. Dillman, S. L. Seagren, K. J. Propert et al., “A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer,” New England Journal of Medicine, vol. 323, no. 14, pp. 940–945, 1990. View at Google Scholar · View at Scopus
  5. Collaborative Group, “Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials,” British Medical Journal, vol. 311, no. 7010, pp. 899–909, 1995. View at Google Scholar
  6. T. Le Chevalier, R. Arriagada, E. Quoix et al., “Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients,” Journal of the National Cancer Institute, vol. 83, no. 6, pp. 417–423, 1991. View at Google Scholar · View at Scopus
  7. H. Jan Keizer, A. B. M. F. Karim, K. Hian Njo et al., “Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy,” Radiotherapy and Oncology, vol. 1, no. 3, pp. 227–234, 1984. View at Google Scholar · View at Scopus
  8. C. Schaake-Koning, H. Bartelink, and B. Hora Adema, “Radiotherapy and cis-diammine dichloroplatinum (II) as a combined treatment modality for inoperable non-small cell lung cancer: a dose finding study,” International Journal of Radiation Oncology Biology Physics, vol. 12, no. 3, pp. 379–383, 1986. View at Google Scholar · View at Scopus
  9. C. Schaake-Koning, B. Maat, P. Van Houtte et al., “Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups,” International Journal of Radiation Oncology Biology Physics, vol. 19, no. 4, pp. 967–972, 1990. View at Google Scholar · View at Scopus
  10. C. Schaake-Koning, W. Van den Bogaert, O. Dalesio et al., “Effects of concomitant cisplatin and radiotherapy on inoperable non-small- cell lung cancer,” New England Journal of Medicine, vol. 326, no. 8, pp. 524–530, 1992. View at Google Scholar · View at Scopus
  11. M. G. Trovo, E. Minatel, G. Franchin et al., “Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 24, no. 7, pp. 11–15, 1992. View at Google Scholar · View at Scopus
  12. A. Aupérin, C. Le Péchoux, J. P. Pignon et al., “Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients,” Annals of Oncology, vol. 17, no. 3, pp. 473–483, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. N. P. Rowell and N. P. O'rourke, “Concurrent chemoradiotherapy in non-small cell lung cancer,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD002140, 2004. View at Google Scholar
  14. A. L. J. Schuster-Uitterhoeve, P. J. M. Van De Vaart, C. C. E. Schaake-Koning et al., “Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer,” European Journal of Cancer A, vol. 32, no. 8, pp. 1314–1319, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. A. L. J. Schuster-Uitterhoeve, M. C. C. M. Hulshof, D. Gonzalez Gonzalez, M. Koolen, and P. Sminia, “Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer (NSCLC),” Radiotherapy and Oncology, vol. 28, no. 3, pp. 247–251, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. J. Uitterhoeve, J. S. A. Belderbos, M. G. J. Koolen et al., “Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancerresults of the EORTC 08912 phase I/II study,” European Journal of Cancer, vol. 36, no. 5, pp. 592–600, 2000. View at Publisher · View at Google Scholar
  17. G. Clamon, J. Herndon, W. Eaton et al., “A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: a phase II trial of cancer and leukemia group B,” Cancer Investigation, vol. 12, no. 3, pp. 273–282, 1994. View at Google Scholar · View at Scopus
  18. W. J. Curran, C. B. Scott, and C. J. Langer, “Long-term benefit is observed in a phase III comparison of sequential versus concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410,” Proceedings of the American Society of Clinical Oncology, vol. 22, p. 621, 2003, abstract no. 2499. View at Google Scholar
  19. P. Fournel, G. Robinet, P. Thomas et al., “Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study,” Journal of Clinical Oncology, vol. 23, no. 25, pp. 5910–5917, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. K. Furuse, M. Fukuoka, M. Kawahara et al., “Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 17, no. 9, pp. 2692–2699, 1999. View at Google Scholar · View at Scopus
  21. H. C. Ulutin, M. Güden, K. Oysul, S. Sürenkök, and Y. Pak, “Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer,” Radiation Medicine, vol. 18, no. 2, pp. 93–96, 2000. View at Google Scholar · View at Scopus
  22. P. Zatloukal, L. Petruzelka, M. Zemanova et al., “Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study,” Lung Cancer, vol. 46, no. 1, pp. 87–98, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. Belderbos, L. Uitterhoeve, N. van Zandwijk et al., “Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973),” European Journal of Cancer, vol. 43, no. 1, pp. 114–121, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. A. Aupérin, C. Le Péchoux, E. Rolland et al., “Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 28, no. 13, pp. 2181–2190, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. N. O'Rourke, M. Roqué I Figuls, N. Farré Bernadó, and F. Macbeth, “Concurrent chemoradiotherapy in non-small cell lung cancer,” Cochrane Database of Systematic Reviews, vol. 6, Article ID CD002140, 2010. View at Google Scholar
  26. B. Jeremic and C. Koning, “Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again,” Journal of Clinical Oncology, vol. 26, no. 10, pp. e1–e2, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. E. E. Vokes, “Optimal therapy for unresectable stage III non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 23, no. 25, pp. 5853–5855, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. M. L. G. Janssen-Heijnen, S. Smulders, V. E. P. P. Lemmens, F. W. J. M. Smeenk, H. J. A. A. Van Geffen, and J. W. W. Coebergh, “Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer,” Thorax, vol. 59, no. 7, pp. 602–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Pignon, A. Gregor, C. Schaake Koning, A. Roussel, M. Van Glabbeke, and P. Scalliet, “Age has no impact on acute and late toxicity of curative thoracic radiotherapy,” Radiotherapy and Oncology, vol. 46, no. 3, pp. 239–248, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Socinski, “Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy,” Clinical Lung Cancer, vol. 5, no. 5, pp. 274–289, 2004. View at Google Scholar · View at Scopus
  31. I. Takata, H. Ueoka, K. Kiura et al., “Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer,” Acta Medica Okayama, vol. 56, no. 5, pp. 261–266, 2002. View at Google Scholar · View at Scopus
  32. A. L. J. Uitterhoeve, M. G. J. Koolen, R. M. van Os et al., “Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer,” Radiation Oncology, vol. 2, no. 1, Article ID 27, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. C. L. Zuur, Y. J. W. Simis, R. S. Verkaik et al., “Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer,” Radiotherapy and Oncology, vol. 89, no. 1, pp. 38–43, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. H. Bartelink, R. F. Kallman, D. Rapacchietta, and G. A. M. Hart, “Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum(II) and irradiation,” Radiotherapy and Oncology, vol. 6, no. 1, pp. 61–74, 1986. View at Google Scholar · View at Scopus
  35. P. G. Rose, B. N. Bundy, E. B. Watkins et al., “Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer,” New England Journal of Medicine, vol. 340, no. 15, pp. 1144–1153, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. D. Ball, J. Bishop, J. Smith et al., “A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial,” Radiotherapy and Oncology, vol. 52, no. 2, pp. 129–136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. M. Groen, A. H. W. van der Leest, E. Fokkema et al., “Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study,” Annals of Oncology, vol. 15, no. 3, pp. 427–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. D. R. Spigel, J. D. Hainsworth, D. A. Yardley et al., “Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab,” Journal of Clinical Oncology, vol. 28, no. 1, pp. 43–48, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. K. Kelly, K. Chansky, L. E. Gaspar et al., “Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023,” Journal of Clinical Oncology, vol. 26, no. 15, pp. 2450–2456, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. E. E. Schaake, T. S. Aukema, J. Belderbos et al., “Cetuximab in combination with concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: a feasibility study,” European Journal of Clinical and Medical Oncology. In press.
  41. A. Brade, A. Bezjak, R. MacRae et al., “A phase II study of concurrent pemetrexed/cisplatin/radiation (RT) for unresectable stage IIIA/b non-small cell lung cancer (NSLC),” Journal of Clinical Oncology, vol. 28, article S15, 2010. View at Google Scholar
  42. I. S. Grills, D. Yan, A. A. Martinez, F. A. Vicini, J. W. Wong, and L. L. Kestin, “Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 57, no. 3, pp. 875–890, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Murshed, H. H. Liu, Z. Liao et al., “Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 4, pp. 1258–1267, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. M. Schwarz, M. Alber, J. V. Lebesque, B. J. Mijnheer, and E. M. F. Damen, “Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 2, pp. 561–570, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus